Binfeng Liu

723 total citations
43 papers, 442 citations indexed

About

Binfeng Liu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Binfeng Liu has authored 43 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Binfeng Liu's work include Ferroptosis and cancer prognosis (16 papers), Cancer-related molecular mechanisms research (13 papers) and Glioma Diagnosis and Treatment (9 papers). Binfeng Liu is often cited by papers focused on Ferroptosis and cancer prognosis (16 papers), Cancer-related molecular mechanisms research (13 papers) and Glioma Diagnosis and Treatment (9 papers). Binfeng Liu collaborates with scholars based in China, United States and United Kingdom. Binfeng Liu's co-authors include Chao Tu, Chengyao Feng, Hong Li, Zhihong Li, Zhendong Liu, Jialin Wang, Yanbiao Wang, Zhongyue Liu, Chenbei Li and Yanzheng Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Binfeng Liu

41 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Binfeng Liu China 13 167 127 106 79 55 43 442
Tingwei Lu China 11 123 0.7× 64 0.5× 38 0.4× 58 0.7× 33 0.6× 20 332
Ali Saeed United States 9 55 0.3× 49 0.4× 40 0.4× 117 1.5× 82 1.5× 19 484
Min-Young Choi South Korea 14 89 0.5× 253 2.0× 187 1.8× 74 0.9× 20 0.4× 26 618
Xiaohui Chen China 11 158 0.9× 80 0.6× 50 0.5× 118 1.5× 49 0.9× 39 366
Qiuxia Dong China 8 131 0.8× 43 0.3× 74 0.7× 198 2.5× 33 0.6× 18 537
Hélène Renard France 9 153 0.9× 104 0.8× 104 1.0× 193 2.4× 14 0.3× 11 737
Osama Hussein Egypt 14 129 0.8× 75 0.6× 219 2.1× 61 0.8× 19 0.3× 39 483

Countries citing papers authored by Binfeng Liu

Since Specialization
Citations

This map shows the geographic impact of Binfeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binfeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binfeng Liu more than expected).

Fields of papers citing papers by Binfeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binfeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binfeng Liu. The network helps show where Binfeng Liu may publish in the future.

Co-authorship network of co-authors of Binfeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Binfeng Liu. A scholar is included among the top collaborators of Binfeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binfeng Liu. Binfeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Binfeng, Wei Li, Chengyao Feng, et al.. (2025). PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma. Signal Transduction and Targeted Therapy. 10(1). 165–165. 1 indexed citations
2.
Liu, Binfeng, et al.. (2025). Identification and validation of SAC3D1 as a prognostic biomarker promoting the development of osteosarcoma. Scientific Reports. 15(1). 19473–19473.
3.
Feng, Chengyao, Wenchao Zhang, Lin Qi, et al.. (2024). Mitigation of Cisplatin-Induced Nephrotoxicity and Augmentation of Anticancer Potency via Tea Polyphenol Nanoparticles’ Codelivery of siRNA from CRISPR/Cas9 Screened Targets. ACS Applied Materials & Interfaces. 16(44). 59721–59737. 5 indexed citations
4.
Zhang, Zhiming, et al.. (2024). SPP1 could be an immunological and prognostic biomarker: From pan‐cancer comprehensive analysis to osteosarcoma validation. The FASEB Journal. 38(14). e23783–e23783. 5 indexed citations
5.
Feng, Chengyao, Binfeng Liu, Haodong Xu, et al.. (2024). PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT. Cancer Research. 84(17). 2873–2887. 17 indexed citations
6.
Wang, Siyu, Hua Wang, Chenbei Li, et al.. (2024). Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications. SHILAP Revista de lepidopterología. 5(3). e489–e489. 6 indexed citations
7.
Tu, Chao, Binfeng Liu, Chenbei Li, et al.. (2023). Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma. SHILAP Revista de lepidopterología. 4(5). e369–e369. 4 indexed citations
8.
9.
Liu, Binfeng, Chenbei Li, Chengyao Feng, et al.. (2023). Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma. Frontiers in Immunology. 14. 1178436–1178436. 2 indexed citations
10.
Liu, Zhendong, Xingbo Cheng, Runze Liu, et al.. (2022). DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients. Journal of Molecular Neuroscience. 72(10). 2136–2149. 1 indexed citations
11.
Liu, Runze, Zhendong Liu, Binfeng Liu, et al.. (2022). GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma. Frontiers in Oncology. 12. 726556–726556. 7 indexed citations
12.
Liu, Binfeng, Chengyao Feng, Zhongyue Liu, Chao Tu, & Zhihong Li. (2022). A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity. Frontiers in Pharmacology. 13. 944158–944158. 9 indexed citations
13.
Liu, Zhongyue, Binfeng Liu, Chengyao Feng, et al.. (2022). Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma. Frontiers in Immunology. 13. 1071636–1071636. 11 indexed citations
14.
Li, Ang, et al.. (2021). A meta-analysis of the secondary fractures for osteoporotic vertebral compression fractures after percutaneous vertebroplasty. Medicine. 100(16). e25396–e25396. 14 indexed citations
15.
Liu, Zhendong, Jialin Wang, Yanbiao Wang, et al.. (2021). Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells. Cancer Medicine. 10(15). 5218–5234. 6 indexed citations
16.
Liu, Zhendong, Binfeng Liu, Hongbo Wang, et al.. (2021). ITGB3BP is a potential biomarker associated with poor prognosis of glioma. Journal of Cellular and Molecular Medicine. 26(3). 813–827. 3 indexed citations
17.
Liu, Zhendong, Jialin Wang, Zhibin Han, et al.. (2021). Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients. Molecular Medicine. 27(1). 52–52. 16 indexed citations
18.
Liu, Zirui, et al.. (2021). Staples versus sutures for skin closure in hip arthroplasty: a meta-analysis and systematic review. Journal of Orthopaedic Surgery and Research. 16(1). 735–735. 7 indexed citations
19.
Liu, Binfeng, et al.. (2020). Exploring the Key Genes and Pathways in the Formation of Corneal Scar Using Bioinformatics Analysis. BioMed Research International. 2020(1). 6247489–6247489. 7 indexed citations
20.
Liu, Binfeng, et al.. (2020). Cemented versus uncemented hemiarthroplasty for elderly patients with displaced fracture of the femoral neck. Medicine. 99(33). e21731–e21731. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tingwei Lu Breakdown of academic impact, for papers by Ali Saeed Breakdown of academic impact, for papers by Min-Young Choi Breakdown of academic impact, for papers by Xiaohui Chen Breakdown of academic impact, for papers by Qiuxia Dong Breakdown of academic impact, for papers by Hélène Renard Breakdown of academic impact, for papers by Osama Hussein
Rankless by CCL
2026